Eduardo Candelario-Jalil

Affiliations: 
Neuroscience University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Neurodegeneration,Traumatic Injury,Ischemic Stroke, Neuroinflammation, Blood-Brain Barrier,Matrix Metalloproteinases, Cerebral Ischemia, Neurovascular Injury
Google:
"Eduardo Candelario-Jalil"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Larochelle J, Howell JA, Yang C, et al. (2024) Pharmacological inhibition of receptor-interacting protein kinase 2 (RIPK2) elicits neuroprotective effects following experimental ischemic stroke. Experimental Neurology. 377: 114812
Lavayen BP, Yang C, Larochelle J, et al. (2023) Neuroprotection by the cannabidiol aminoquinone VCE-004.8 in experimental ischemic stroke in mice. Neurochemistry International. 165: 105508
Yang C, Liu L, Lavayen BP, et al. (2022) Therapeutic Benefits of Adropin in Aged Mice After Transient Ischemic Stroke via Reduction of Blood-Brain Barrier Damage. Stroke
Liu L, Yang C, Lavayen BP, et al. (2022) Targeted BRD4 protein degradation by dBET1 ameliorates acute ischemic brain injury and improves functional outcomes associated with reduced neuroinflammation and oxidative stress and preservation of blood-brain barrier integrity. Journal of Neuroinflammation. 19: 168
Candelario-Jalil E, Dijkhuizen RM, Magnus T. (2022) Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities. Stroke. 101161STROKEAHA12203
Yang C, Lavayen BP, Liu L, et al. (2021) Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism. Redox Biology. 48: 102197
Rajagopal S, Yang C, DeMars KM, et al. (2021) Regulation of post-ischemic inflammatory response: A novel function of the neuronal tyrosine phosphatase STEP. Brain, Behavior, and Immunity
Candelario-Jalil E, Paul S. (2020) Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective. Experimental Neurology. 335: 113494
Yang C, Yang Y, DeMars KM, et al. (2020) Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke. Frontiers in Neurology. 11: 887
Bellozi PMQ, Gomes GF, Machado da Silva MC, et al. (2019) A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mice models of Alzheimer's disease. Neuropharmacology. 107785
See more...